STXS official logo STXS
STXS 1-star rating from Upturn Advisory
Stereotaxis Inc (STXS) company logo

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS) 1-star rating from Upturn Advisory
$2.37
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: STXS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $4.25

1 Year Target Price $4.25

Analysts Price Target For last 52 week
$4.25 Target price
52w Low $1.54
Current$2.37
52w High $3.59

Analysis of Past Performance

Type Stock
Historic Profit -44.26%
Avg. Invested days 31
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 221.18M USD
Price to earnings Ratio -
1Y Target Price 4.25
Price to earnings Ratio -
1Y Target Price 4.25
Volume (30-day avg) 4
Beta 1.47
52 Weeks Range 1.54 - 3.59
Updated Date 12/15/2025
52 Weeks Range 1.54 - 3.59
Updated Date 12/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.28

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -78.56%
Operating Margin (TTM) -69.75%

Management Effectiveness

Return on Assets (TTM) -26.42%
Return on Equity (TTM) -170.24%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 221524688
Price to Sales(TTM) 7.35
Enterprise Value 221524688
Price to Sales(TTM) 7.35
Enterprise Value to Revenue 7.37
Enterprise Value to EBITDA -10.06
Shares Outstanding 93324763
Shares Floating 66055267
Shares Outstanding 93324763
Shares Floating 66055267
Percent Insiders 29.27
Percent Institutions 46.53

About Stereotaxis Inc

Exchange NYSE MKT
Headquaters Saint Louis, MO, United States
IPO Launch date 2004-08-12
CEO & Chairman Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 139
Full time employees 139

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.